After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...
The commercial success of the injectable peptide-based weight-loss drugs marketed by Novo Nordisk and Eli Lilly and Company ...
Stanford researchers have discovered BRP, a naturally occurring peptide that suppresses appetite and promotes weight loss, ...
Weight loss supplements are a big industry, but do they actually work? A dietitian explores the evidence, efficacy, and safety of common weight loss supplements.
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
Some people have critiqued Ozempic (semaglutide)—a diabetes medication that can aid in weight loss—for the effects ... Collagen supplements for aging and wrinkles: A paradigm shift in the ...
Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...